{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:06:54Z","timestamp":1789625214674,"version":"build-2803163510"},"reference-count":69,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>Transfusion-related acute lung injury is characterized by the onset of respiratory distress and acute lung injury following blood transfusion, but its pathogenesis remains poorly understood. Generally, a two-hit model is presumed to underlie transfusion-related acute lung injury with the first hit being risk factors present in the transfused patient (such as inflammation), whereas the second hit is conveyed by factors in the transfused donor blood (such as antileukocyte antibodies). At least 80% of transfusion-related acute lung injury cases are related to the presence of donor antibodies such as antihuman leukocyte or antihuman neutrophil antibodies. The remaining cases may be related to nonantibody-mediated factors such as biolipids or components related to storage and ageing of the transfused blood cells. At present, transfusion-related acute lung injury is the leading cause of transfusion-related fatalities and no specific therapy is clinically available. In this article, we critically appraise and discuss recent preclinical (bench) insights related to transfusion-related acute lung injury pathogenesis and their therapeutic potential for future use at the patients\u2019 bedside in order to combat this devastating and possibly fatal complication of transfusion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Sources:<\/jats:title>\n                    <jats:p>We searched the PubMed database (until August 22, 2017).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study Selection:<\/jats:title>\n                    <jats:p>Using terms: \u201cTransfusion-related acute lung injury,\u201d \u201cTRALI,\u201d \u201cTRALI and therapy,\u201d \u201cTRALI pathogenesis.\u201d<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Extraction:<\/jats:title>\n                    <jats:p>English-written articles focusing on transfusion-related acute lung injury pathogenesis, with potential therapeutic implications, were extracted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Synthesis:<\/jats:title>\n                    <jats:p>We have identified potential therapeutic approaches based on the literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>\n                      We propose that the most promising therapeutic strategies to explore are interleukin-10 therapy, down-modulating\n                      <jats:italic toggle=\"yes\">C<\/jats:italic>\n                      -reactive protein levels, targeting reactive oxygen species, or blocking the interleukin-8 receptors; all focused on the transfused recipient. In the long-run, it may perhaps also be advantageous to explore other strategies aimed at the transfused recipient or aimed toward the blood product, but these will require more validation and confirmation first.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ccm.0000000000002989","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T11:08:25Z","timestamp":1517396905000},"page":"e452-e458","source":"Crossref","is-referenced-by-count":62,"title":["Targeting Transfusion-Related Acute Lung Injury: The Journey From Basic Science to Novel Therapies"],"prefix":"10.1097","volume":"46","author":[{"given":"John W.","family":"Semple","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"McVey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Rebetz","sequence":"additional","affiliation":[{"name":"Division of Hematology and Transfusion Medicine, Lund University, Lund, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang M.","family":"Kuebler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick","family":"Kapur","sequence":"additional","affiliation":[{"name":"Division of Hematology and Transfusion Medicine, Lund University, Lund, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20230728","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.tmrv.2017.07.001","article-title":"Analysis of transfusion-related acute lung injury and possible transfusion-related acute lung injury reported to the french hemovigilance network from 2007 to 2013.","volume":"32","author":"Andreu","year":"2018","journal-title":"Transfus Med Rev"},{"key":"R3-20230728","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/CCM.0b013e3181cc4d4b","article-title":"Risk factors and outcome of transfusion-related acute lung injury in the critically ill: A nested case-control study.","volume":"38","author":"Vlaar","year":"2010","journal-title":"Crit Care Med"},{"key":"R4-20230728","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00000433-198712000-00004","article-title":"Fatal transfusion reactions caused by donor antibodies to recipient leukocytes.","volume":"8","author":"Ausley","year":"1987","journal-title":"Am J Forensic Med Pathol"},{"key":"R5-20230728","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1046\/j.1537-2995.2003.00385.x","article-title":"Plasma and lipids from stored platelets cause acute lung injury in an animal model.","volume":"43","author":"Silliman","year":"2003","journal-title":"Transfusion"},{"key":"R6-20230728","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1182\/blood-2011-08-370932","article-title":"Transfusion-related acute lung injury: Incidence and risk factors.","volume":"119","author":"Toy","year":"2012","journal-title":"Blood"},{"key":"R7-20230728","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1097\/CCM.0b013e31825b8e20","article-title":"Transfusion-related acute lung injury in cardiac surgery patients is characterized by pulmonary inflammation and coagulopathy: A prospective nested case-control study.","volume":"40","author":"Vlaar","year":"2012","journal-title":"Crit Care Med"},{"key":"R8-20230728","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1111\/trf.13021","article-title":"Cytokines and clinical predictors in distinguishing pulmonary transfusion reactions.","volume":"55","author":"Roubinian","year":"2015","journal-title":"Transfusion"},{"key":"R9-20230728","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1172\/JCI200318921","article-title":"C-reactive protein: A critical update.","volume":"111","author":"Pepys","year":"2003","journal-title":"J Clin Invest"},{"key":"R10-20230728","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1182\/blood-2015-09-672592","article-title":"C-reactive protein enhances murine antibody-mediated transfusion-related acute lung injury.","volume":"126","author":"Kapur","year":"2015","journal-title":"Blood"},{"key":"R11-20230728","doi-asserted-by":"crossref","first-page":"78048","DOI":"10.18632\/oncotarget.12872","article-title":"Elevation of C-reactive protein levels in patients with transfusion-related acute lung injury.","volume":"7","author":"Kapur","year":"2016","journal-title":"Oncotarget"},{"key":"R12-20230728","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1182\/blood-2016-12-758185","article-title":"T regulatory cells and dendritic cells protect against transfusion-related acute lung injury via IL-10.","volume":"129","author":"Kapur","year":"2017","journal-title":"Blood"},{"key":"R13-20230728","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/bjh.13459","article-title":"Antibody-mediated transfusion-related acute lung injury; from discovery to prevention.","volume":"170","author":"Peters","year":"2015","journal-title":"Br J Haematol"},{"key":"R14-20230728","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/vox.12383","article-title":"Underdiagnosing of antibody-mediated transfusion-related acute lung injury: Evaluation of cellular-based versus bead-based techniques.","volume":"111","author":"van Stein","year":"2016","journal-title":"Vox Sang"},{"key":"R15-20230728","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.blre.2014.09.007","article-title":"Pathogenesis of non-antibody mediated transfusion-related acute lung injury from bench to bedside.","volume":"29","author":"Peters","year":"2015","journal-title":"Blood Rev"},{"key":"R16-20230728","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1378\/chest.09-0841","article-title":"Long-term survival and quality of life after transfusion-associated pulmonary edema in critically ill medical patients.","volume":"137","author":"Li","year":"2010","journal-title":"Chest"},{"key":"R17-20230728","first-page":"720950","article-title":"Mechanical ventilation and the titer of antibodies as risk factors for the development of transfusion-related lung injury.","volume":"2012","author":"Vlaar","year":"2012","journal-title":"Crit Care Res Pract"},{"key":"R18-20230728","doi-asserted-by":"crossref","first-page":"339","DOI":"10.21037\/atm.2017.04.37","article-title":"Low levels of interleukin-10 in patients with transfusion-related acute lung injury.","volume":"5","author":"Kapur","year":"2017","journal-title":"Ann Transl Med"},{"key":"R19-20230728","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1111\/j.1537-2995.2011.03186.x","article-title":"Identification of lipids that accumulate during the routine storage of prestorage leukoreduced red blood cells and cause acute lung injury.","volume":"51","author":"Silliman","year":"2011","journal-title":"Transfusion"},{"key":"R20-20230728","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.2174\/1381612811209023249","article-title":"Prevention of non-immune mediated transfusion-related acute lung injury; from blood bank to patient.","volume":"18","author":"van Bruggen","year":"2012","journal-title":"Curr Pharm Des"},{"key":"R21-20230728","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/SLA.0000000000001648","article-title":"Acid sphingomyelinase inhibition in stored erythrocytes reduces transfusion-associated lung inflammation.","volume":"265","author":"Hoehn","year":"2017","journal-title":"Ann Surg"},{"key":"R22-20230728","doi-asserted-by":"crossref","first-page":"L625","DOI":"10.1152\/ajplung.00317.2016","article-title":"Acid sphingomyelinase mediates murine acute lung injury following transfusion of aged platelets.","volume":"312","author":"McVey","year":"2017","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R23-20230728","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jss.2014.06.003","article-title":"Blood transfusion products contain mitochondrial DNA damage-associated molecular patterns: A potential effector of transfusion-related acute lung injury.","volume":"191","author":"Lee","year":"2014","journal-title":"J Surg Res"},{"key":"R24-20230728","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/j.1537-2995.2011.03099.x","article-title":"Microparticles in stored red blood cells as potential mediators of transfusion complications.","volume":"51","author":"Jy","year":"2011","journal-title":"Transfusion"},{"key":"R25-20230728","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jamcollsurg.2011.12.032","article-title":"Microparticles from stored red blood cells activate neutrophils and cause lung injury after hemorrhage and resuscitation.","volume":"214","author":"Belizaire","year":"2012","journal-title":"J Am Coll Surg"},{"key":"R26-20230728","doi-asserted-by":"crossref","first-page":"L364","DOI":"10.1152\/ajplung.00354.2011","article-title":"Microparticles and acute lung injury.","volume":"303","author":"McVey","year":"2012","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R27-20230728","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/vox.12092","article-title":"The effect of platelet-derived microparticles in stored apheresis platelet concentrates on polymorphonuclear leucocyte respiratory burst.","volume":"106","author":"Xie","year":"2014","journal-title":"Vox Sang"},{"key":"R28-20230728","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/trf.12952","article-title":"Platelet-derived microparticles induce polymorphonuclear leukocyte-mediated damage of human pulmonary microvascular endothelial cells.","volume":"55","author":"Xie","year":"2015","journal-title":"Transfusion"},{"key":"R29-20230728","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1182\/blood-2008-07-166264","article-title":"Loss of red cell chemokine scavenging promotes transfusion-related lung inflammation.","volume":"113","author":"Mangalmurti","year":"2009","journal-title":"Blood"},{"key":"R30-20230728","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1537-2995.2011.03352.x","article-title":"Storage time of blood products and transfusion-related acute lung injury.","volume":"52","author":"Middelburg","year":"2012","journal-title":"Transfusion"},{"key":"R31-20230728","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1097\/CCM.0000000000000323","article-title":"Prospective study on the clinical course and outcomes in transfusion-related acute lung injury*.","volume":"42","author":"Looney","year":"2014","journal-title":"Crit Care Med"},{"key":"R32-20230728","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1172\/JCI27238","article-title":"Neutrophils and their Fc gamma receptors are essential in a mouse model of transfusion-related acute lung injury.","volume":"116","author":"Looney","year":"2006","journal-title":"J Clin Invest"},{"key":"R33-20230728","first-page":"3450","article-title":"Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury.","volume":"119","author":"Looney","year":"2009","journal-title":"J Clin Invest"},{"key":"R34-20230728","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor.","volume":"19","author":"Moore","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"R35-20230728","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1161\/01.CIR.102.18.2165","article-title":"Direct proinflammatory effect of C-reactive protein on human endothelial cells.","volume":"102","author":"Pasceri","year":"2000","journal-title":"Circulation"},{"key":"R36-20230728","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1084\/jem.20110159","article-title":"MHC class I-specific antibody binding to nonhematopoietic cells drives complement activation to induce transfusion-related acute lung injury in mice.","volume":"208","author":"Strait","year":"2011","journal-title":"J Exp Med"},{"key":"R37-20230728","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/nature04672","article-title":"Targeting C-reactive protein for the treatment of cardiovascular disease.","volume":"440","author":"Pepys","year":"2006","journal-title":"Nature"},{"key":"R38-20230728","doi-asserted-by":"crossref","first-page":"124021","DOI":"10.1155\/2013\/124021","article-title":"Interpretation of C-reactive protein concentrations in critically ill patients.","volume":"2013","author":"Lelubre","year":"2013","journal-title":"Biomed Res Int"},{"key":"R39-20230728","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1172\/JCI61303","article-title":"Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury.","volume":"122","author":"Caudrillier","year":"2012","journal-title":"J Clin Invest"},{"key":"R40-20230728","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1182\/blood-2010-05-284570","article-title":"Recipient T lymphocytes modulate the severity of antibody-mediated transfusion-related acute lung injury.","volume":"116","author":"Fung","year":"2010","journal-title":"Blood"},{"key":"R41-20230728","doi-asserted-by":"crossref","first-page":"e31357","DOI":"10.1371\/journal.pone.0031357","article-title":"Intravenous immunoglobulin prevents murine antibody-mediated acute lung injury at the level of neutrophil reactive oxygen species (ROS) production.","volume":"7","author":"Semple","year":"2012","journal-title":"PLoS One"},{"key":"R42-20230728","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1182\/blood-2013-11-536755","article-title":"Peripheral blood monocyte-derived chemokine blockade prevents murine transfusion-related acute lung injury (TRALI).","volume":"123","author":"McKenzie","year":"2014","journal-title":"Blood"},{"key":"R43-20230728","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/ajcp\/112.2.216","article-title":"The pathology of transfusion-related acute lung injury.","volume":"112","author":"Dry","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"R44-20230728","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1182\/blood-2004-07-2929","article-title":"Transfusion-related acute lung injury.","volume":"105","author":"Silliman","year":"2005","journal-title":"Blood"},{"key":"R45-20230728","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1161\/ATVBAHA.113.301206","article-title":"Anti-human neutrophil antigen-3a induced transfusion-related acute lung injury in mice by direct disturbance of lung endothelial cells.","volume":"33","author":"Bayat","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R46-20230728","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1182\/blood-2006-05-025106","article-title":"Donor antibodies to HNA-3a implicated in TRALI reactions prime neutrophils and cause PMN-mediated damage to human pulmonary microvascular endothelial cells in a two-event in vitro model.","volume":"109","author":"Silliman","year":"2007","journal-title":"Blood"},{"key":"R47-20230728","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.4049\/jimmunol.155.3.1428","article-title":"IL-8 induces neutrophil chemotaxis predominantly via type I IL-8 receptors.","volume":"155","author":"Hammond","year":"1995","journal-title":"J Immunol"},{"key":"R48-20230728","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1126\/science.1840701","article-title":"Structure and functional expression of a human interleukin-8 receptor.","volume":"253","author":"Holmes","year":"1991","journal-title":"Science"},{"key":"R49-20230728","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.1158\/1078-0432.CCR-07-4843","article-title":"The interleukin-8 pathway in cancer.","volume":"14","author":"Waugh","year":"2008","journal-title":"Clin Cancer Res"},{"key":"R50-20230728","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pharmthera.2008.10.005","article-title":"CXCR2 antagonists for the treatment of pulmonary disease.","volume":"121","author":"Chapman","year":"2009","journal-title":"Pharmacol Ther"},{"key":"R51-20230728","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S2213-2600(16)30227-2","article-title":"Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trial.","volume":"4","author":"O\u2019Byrne","year":"2016","journal-title":"Lancet Respir Med"},{"key":"R52-20230728","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1503\/cmaj.130375","article-title":"Intravenous immunoglobulin as clinical immune-modulating therapy.","volume":"187","author":"Gilardin","year":"2015","journal-title":"CMAJ"},{"key":"R53-20230728","first-page":"674","article-title":"Immunomodulation by IVIg and the role of Fc-gamma receptors: Classic mechanisms of action after all?","volume":"5","author":"Nagelkerke","year":"2014","journal-title":"Front Immunol"},{"key":"R54-20230728","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1046\/j.1537-2995.2001.41020264.x","article-title":"Transfusion-related acute lung injury after the infusion of IVIG.","volume":"41","author":"Rizk","year":"2001","journal-title":"Transfusion"},{"key":"R55-20230728","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/01.smj.0000182176.71475.a9","article-title":"Acute respiratory distress syndrome in a child with Kawasaki disease.","volume":"98","author":"Palmer","year":"2005","journal-title":"South Med J"},{"key":"R56-20230728","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/ajh.21185","article-title":"Transfusion-related acute lung injury following intravenous anti-D administration in an adolescent.","volume":"83","author":"Berger-Achituv","year":"2008","journal-title":"Am J Hematol"},{"key":"R57-20230728","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3899\/jrheum.090725","article-title":"Images in rheumatology. Transfusion-related acute lung injury during intravenous immunoglobulin treatment.","volume":"37","author":"Voulgari","year":"2010","journal-title":"J Rheumatol"},{"key":"R58-20230728","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria.","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"R59-20230728","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nm.3887","article-title":"Diabetes primes neutrophils to undergo NETosis, which impairs wound healing.","volume":"21","author":"Wong","year":"2015","journal-title":"Nat Med"},{"key":"R60-20230728","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/ALN.0000000000000605","article-title":"Mechanical ventilation induces neutrophil extracellular trap formation.","volume":"122","author":"Yildiz","year":"2015","journal-title":"Anesthesiology"},{"key":"R61-20230728","doi-asserted-by":"crossref","first-page":"6335","DOI":"10.1182\/blood-2012-01-405183","article-title":"Extracellular DNA traps are associated with the pathogenesis of TRALI in humans and mice.","volume":"119","author":"Thomas","year":"2012","journal-title":"Blood"},{"key":"R62-20230728","doi-asserted-by":"crossref","first-page":"9813","DOI":"10.1073\/pnas.0909927107","article-title":"Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis.","volume":"107","author":"Hakkim","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R63-20230728","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1177\/1060028014535199","article-title":"Dornase alfa for non-cystic fibrosis pediatric pulmonary atelectasis.","volume":"48","author":"Thornby","year":"2014","journal-title":"Ann Pharmacother"},{"key":"R64-20230728","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.4049\/jimmunol.174.4.2084","article-title":"Complement inhibitor of C5 activation from the soft tick Ornithodoros moubata.","volume":"174","author":"Nunn","year":"2005","journal-title":"J Immunol"},{"key":"R65-20230728","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1182\/blood-2014-03-562876","article-title":"Aspirin-triggered 15-epi-lipoxin A4 regulates neutrophil-platelet aggregation and attenuates acute lung injury in mice.","volume":"124","author":"Ortiz-Mu\u00f1oz","year":"2014","journal-title":"Blood"},{"key":"R66-20230728","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/jth.13335","article-title":"Platelets are dispensable for antibody-mediated transfusion-related acute lung injury in the mouse.","volume":"14","author":"Hechler","year":"2016","journal-title":"J Thromb Haemost"},{"key":"R67-20230728","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1365-2044.2011.07054.x","article-title":"The effect of aspirin in transfusion-related acute lung injury in critically ill patients.","volume":"67","author":"Tuinman","year":"2012","journal-title":"Anaesthesia"},{"key":"R68-20230728","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1160\/TH12-03-0180","article-title":"Viewpoint: Reversible nature of platelet binding causing transfusion-related acute lung injury (TRALI) syndrome may explain dyspnea after ticagrelor and elinogrel.","volume":"108","author":"Serebruany","year":"2012","journal-title":"Thromb Haemost"},{"key":"R69-20230728","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000354876","article-title":"Dyspnea and reversibility of antiplatelet agents: Ticagrelor, elinogrel, cangrelor, and beyond.","volume":"127","author":"Serebruany","year":"2014","journal-title":"Cardiology"},{"key":"R70-20230728","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s40256-014-0071-6","article-title":"Dyspnea and reversibility profile of P2Y12 antagonists: Systematic review of new antiplatelet drugs.","volume":"14","author":"Caldeira","year":"2014","journal-title":"Am J Cardiovasc Drugs"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003246-201805000-00049","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T03:19:29Z","timestamp":1690514369000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003246-201805000-00049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":69,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000002989","relation":{},"ISSN":["0090-3493"],"issn-type":[{"value":"0090-3493","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]}}}